Literatur
-
1
Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C.. French-American-British (FAB) Co-operative group .
Proposals
for the classification of the acute leukaemias.
Br J Haematol.
1976;
33
451-458
-
2
Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C. A report of the French-American-British Cooperative Group .
Proposed
revised criteria for the classification of acute myeloid leukemia.
Ann
Intern Med.
1985;
103
620-625
-
3
Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, Sultan C.
Proposal
for the classification of myelodysplastic syndromes.
Br
J Haematol.
1982;
51
189-199
-
4
Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, Sultan C.
Proposal
for the recognition of minimally differentiated acute myeloid leukaemia
(AML-M0).
Br J Haematol.
1991;
78
325-329
-
5
Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, Sultan C.
A
variant form of hypergranular promyelocytic leukaemia (M3).
Br
J Haematol.
1980;
44
169-170
-
6
Béné M C, Bernier M, Castoldi G, Faure G C, Knapp W, Ludwig W -D, Matutes E, Orfao A, van’t Veer M B.
Impact
of immunophenotyping on management of acute leukemias.
Haematologica.
1999;
84
1024-1034
-
7
Béné M C, Castoldi G, Knapp W, Ludwig W -D, Matutes E, Orfao A, van’t Veer M B. European Group for the Immunological Characterization of Leukemias
(EGIL) .
Proposal for the immunological classification
of acute leukemias.
Leukemia.
1995;
9
1783-1786
-
8
Goasguen J E, Matsuo T, Cox C, Bennett J M.
Evaluation
of the dysmyelopoiesis in 336 patients with de novo acute myeloid
leukemia: Major importance of dysgranulopoiesis for remission and survival.
Leukemia.
1992;
6
520-525
-
9
Greenberg P, Cox C, LeBeau M. et
al .
International scoring system for evaluating prognosis
in myelodysplastic syndromes.
Blood.
1997;
89
2079-2088
-
10
Haferlach T.
More individual markers
are necessary for patients with acute myeloid leukemia (AML). Does
cytomorphology or cytogenetics define the biological entity?.
Leukemia.
1996;
10
5-9
-
11
Haferlach T, Schoch C, Löffler H, Gassmann W, Kern W, Schnittger S, Fonatsch C, Ludwig W -D, Wuchter C, Schlegelberger B, Staib P, Reichle A, Kubica U, Eimermacher H, Balleisen L, Grüneisen A, Haase D, Aul C, Karow J, Lengfelder E, Wörmann B, Heinecke A, Sauerland M C, Büchner T, Hiddemann W.
Morphologic dysplasia
in de novo acute myeloid leukemia (AML) is related to unfavorable
cytogenetics but has no independent prognostic relevance under the conditions
of intensive induction therapy: results of a multiparameter analysis
on 614 patients treated within the German AML Cooperative Group
(AMLCG) studies.
J Clin Oncol.
(in press)
-
12
Lengfelder E, Hehlmann R, Büchner Th.
Aktuelle
Therapiekonzepte bei akuter Promyelozytenleukämie.
Dtsch
Med Wochenschr.
2001;
39
1073-1079
-
13 Löffler H, Rastetter J. Atlas der klinischen
Hämatologie. 5. Aufl. Berlin: Springer 1999
-
14
Harris N L, Jaffe E S, Diebold J, Flandrin G, Müller-Hermelink H K, Vardiman J, Lister T A, Bloomfield C D.
World Health
Orginization classification of neoplastic diseases of the hematopoietic
and lymphoid tissues: Report of the clinical advisory committee
meeting - Airlie House, Virginia, November 1997.
J
Clin Oncol.
1999;
17
3835-3849
-
15
Second MIC Cooperative Study
Group .
Morphologic, Immunologic and cytogenetic (MIC)
working classification of the acute myeloid leukaemias.
Br
J Haematol.
1988;
68
487-494
-
16 World Health Organisation:
Classification of Tumours: Pathology & Genetics. IARCPress,
Lyon Tumours of Haematopoietic and Lymphoid Tissues.
Ed. E. S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman 2001
Korrespondenz
Priv.-Doz. Dr. med. Dr. phil. T. Haferlach
Labor für Leukämiediagnostik, Medizinische
Klinik und Poliklinik III, Klinikum Großhadern, Ludwig-Maximilians-Universität
Marchioninistraße 15
81377 München
Phone: 089/70954970
Fax: 089/70954971
Email: torsten.haferlach@med3.med.uni-muenchen.de
